Enervit exercises the purchase option on 1% of Enervit Nutrition, a joint venture between ROVI and Enervit


No votes yet
 
Related
ROVI announces the commencement of the assessment process to obtain marketing authorisation for Doria® in the European Union
ROVI filed its application for marketing authorisation for Doria® with the European health authorities, the European Medicines Agency (EMA...
2 min
31/01/2020